These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10570030)

  • 1. A method for estimating pharmacokinetic risks of concentration-dependent drug interactions from preclinical data.
    Ramanathan M
    Drug Metab Dispos; 1999 Dec; 27(12):1479-87. PubMed ID: 10570030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stochastic prediction of CYP3A-mediated inhibition of midazolam clearance by ketoconazole.
    Chien JY; Lucksiri A; Ernest CS; Gorski JC; Wrighton SA; Hall SD
    Drug Metab Dispos; 2006 Jul; 34(7):1208-19. PubMed ID: 16611859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
    Mentré F; Mallet A; Steimer JL
    Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism-based inhibition of cytochrome P450 enzymes: an evaluation of early decision making in vitro approaches and drug-drug interaction prediction methods.
    Grime KH; Bird J; Ferguson D; Riley RJ
    Eur J Pharm Sci; 2009 Feb; 36(2-3):175-91. PubMed ID: 19013237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and specification of physiologically based pharmacokinetic models for use in risk assessment.
    Clewell RA; Clewell HJ
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):129-43. PubMed ID: 18077066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating physiological and biochemical mechanisms into pharmacokinetic-pharmacodynamic models: a conceptual framework.
    Dahl SG; Aarons L; Gundert-Remy U; Karlsson MO; Schneider YJ; Steimer JL; Trocóniz IF
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):2-12. PubMed ID: 19686541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative performance of different stochastic methods to simulate drug exposure and variability in a population.
    Tam VH; Kabbara S
    Diagn Microbiol Infect Dis; 2006 Oct; 56(2):185-8. PubMed ID: 16930922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hill equation: a review of its capabilities in pharmacological modelling.
    Goutelle S; Maurin M; Rougier F; Barbaut X; Bourguignon L; Ducher M; Maire P
    Fundam Clin Pharmacol; 2008 Dec; 22(6):633-48. PubMed ID: 19049668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds.
    Pelekis M; Gephart LA; Lerman SE
    Regul Toxicol Pharmacol; 2001 Feb; 33(1):12-20. PubMed ID: 11259175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualism in plant populations: using stochastic differential equations to model individual neighbourhood-dependent plant growth.
    Lv Q; Schneider MK; Pitchford JW
    Theor Popul Biol; 2008 Aug; 74(1):74-83. PubMed ID: 18619390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stochasticity in physiologically based kinetics models: implications for cancer risk assessment.
    Péry AR; Bois FY
    Risk Anal; 2009 Aug; 29(8):1182-91. PubMed ID: 19508449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.
    Marino DJ; Starr TB
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):285-300. PubMed ID: 17949874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-drug interactions: predictive in vitro models of in vivo interactions. Round table no. 6.XV].
    Weber F; Becquemont L
    Therapie; 2000; 55(4):569-75. PubMed ID: 11098737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel model for the prediction of drug-drug interactions in humans based on in vitro cytochrome p450 phenotypic data.
    Lu C; Miwa GT; Prakash SR; Gan LS; Balani SK
    Drug Metab Dispos; 2007 Jan; 35(1):79-85. PubMed ID: 17020957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stochastic differential equation for exposure yields a beta distribution.
    Flynn MR
    Ann Occup Hyg; 2004 Jul; 48(5):491-7. PubMed ID: 15240336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint propagation of variability and imprecision in assessing the risk of groundwater contamination.
    Baudrit C; Guyonnet D; Dubois D
    J Contam Hydrol; 2007 Aug; 93(1-4):72-84. PubMed ID: 17321003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Q-DIPS: current approach to prediction of drug interactions].
    Leemann T; Dayer P
    Schweiz Med Wochenschr; 1992 Dec; 122(50):1930-2. PubMed ID: 1465597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
    Filipsson AF; Sand S; Nilsson J; Victorin K
    Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.